Phase II Clinical Trial of Clenbuterol in Adult Patients With Pompe Disease
Status:
Not yet recruiting
Trial end date:
2025-12-30
Target enrollment:
Participant gender:
Summary
The goals of this study are to determine safety and efficacy with regard to motor function of
oral clenbuterol in combination with ERT in subjects with LOPD